scispace - formally typeset
Journal ArticleDOI

A thermoresponsive bubble-generating liposomal system for triggering localized extracellular drug delivery.

TLDR
A thermoresponsive bubble-generating liposomal system is proposed for triggering localized extracellular drug delivery and may also provide an ability to monitor a temperature-controlled drug delivery process.
Abstract
The therapeutic effectiveness of chemotherapy is optimal only when tumor cells are subjected to a maximum drug exposure. To increase the intratumoral drug concentration and thus the efficacy of chemotherapy, a thermoresponsive bubble-generating liposomal system is proposed for triggering localized extracellular drug delivery. The key component of this liposomal formulation is the encapsulated ammonium bicarbonate (ABC), which is used to create the transmembrane gradient needed for a highly efficient encapsulation of doxorubicin (DOX). At an elevated temperature (42 °C), decomposition of ABC generates CO(2) bubbles, creating permeable defects in the lipid bilayer that rapidly release DOX and instantly increase the drug concentration locally. Because the generated CO(2) bubbles are hyperechogenic, they also enhance ultrasound imaging. Consequently, this new liposomal system encapsulated with ABC may also provide an ability to monitor a temperature-controlled drug delivery process.

read more

Citations
More filters
Journal ArticleDOI

Stimuli-responsive nanocarriers for drug delivery

TL;DR: Recent advances in the design of nanoscale stimuli-responsive systems that are able to control drug biodistribution in response to specific stimuli, either exogenous (variations in temperature, magnetic field, ultrasound intensity, light or electric pulses) or endogenous (changes in pH, enzyme concentration or redox gradients).
Journal ArticleDOI

Engineered Nanoparticles for Drug Delivery in Cancer Therapy

TL;DR: It is anticipated that precisely engineered nanoparticles will emerge as the next-generation platform for cancer therapy and many other biomedical applications.
Journal ArticleDOI

Cancer nanomedicine: a review of recent success in drug delivery

TL;DR: The clinical trials of Onivyde leading to its approval in 2015 by the Food and Drug Adminstration are highlighted as a case study in the recent clinical success of nanomedicine against cancer.
References
More filters
Journal ArticleDOI

Drug Delivery Systems: Entering the Mainstream

TL;DR: There is considerable interest in exploiting the advantages of DDS for in vivo delivery of new drugs derived from proteomics or genomics research and for their use in ligand-targeted therapeutics.
Journal ArticleDOI

Doxil®--the first FDA-approved nano-drug: lessons learned.

TL;DR: This review summarizes historical and scientific perspectives of Doxil development and lessons learned from its development and 20 years of its use and demonstrates the obligatory need for applying an understanding of the cross talk between physicochemical, nano-technological, and biological principles.
Journal ArticleDOI

Ligand-targeted therapeutics in anticancer therapy

TL;DR: Cytotoxic chemotherapy or radiotherapy of cancer is limited by serious, sometimes life-threatening, side effects that arise from toxicities to sensitive normal cells because the therapies are not selective for malignant cells, so how can selectivity be improved?
Journal ArticleDOI

Nanomedicine--challenge and perspectives.

TL;DR: This Review gives an overview of selected recent developments and applications of nanomedicine.
Journal ArticleDOI

Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy.

TL;DR: This review is mainly to compare the therapeutic effect of current clinically approved liposome-based drugs with free drugs, and to also determine the clinical effect via liposomal variations in lipid composition.
Related Papers (5)